Evidence map›Paper›PMID 37884300›Full record

ArticleAJNR. American journal of neuroradiology2023

Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.

Arian Lasocki, Michael E Buckland, Tahlia Molinaro, Jing Xie, Frank Gaillard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AJNR. American journal of neuroradiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Reply.AJNR. American journal of neuroradiology · 2024
    Article
  3. A Note of Caution Regarding Single-Arm 1p or 19q Deletion inAJNR. American journal of neuroradiology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Arian LasockiFrom the Department of Cancer Imaging (A.L.), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia arian.lasocki@petermac.org.ORCID 0000-0001-8176-3015
Michael E BucklandDepartment of Neuropathology (M.E.B.), Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.ORCID 0000-0003-4755-6471
Tahlia MolinaroDepartment of Medical Oncology (T.M.), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0003-0355-5573
Jing XieCentre for Biostatistics and Clinical Trials (J.X.), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID 0000-0001-6694-3587
Frank GaillardDepartment of Radiology (A.L., F.G.), The University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0002-2382-872X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMATERIALS AND

methodsOne hundred twenty-one

resultsThe cohort comprised 65 tumors without 1p or 19q deletion, 12 unideleted tumors, and 44 codeleted. The proportion of unideleted tumors demonstrating the T2-FLAIR mismatch sign (33%) was similar to that in tumors without deletion (49%;

conclusions

Indexed as

AstrocytomaBrain NeoplasmsGliomaOligodendrogliomaChromosomes, Human, Pair 1Chromosomes, Human, Pair 19HumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMutationIsocitrate Dehydrogenase

Identifiers

PMID37884300
PMCPMC10631530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.